Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
for Recurrent Ovarian High Grade Serous Adenocarcinoma
Drug: Olaparib
Sites in Irvine, Orange +10 more locations
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 18+
Code: NCT04633239·Phase 1·Recruiting·Listed Nov 2020